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Abstract: Bacteriocin-producing (Bac+) lactic acid bacteria (LAB) comprising selected strains of
Lactobacillus curvatus, Lactococcus lactis, Pediococcus acidilactici, and Enterococcus faecium and thailandicus
were examined for inhibition of Listeria monocytogenes during hotdog challenge studies. The Bac+
strains, or their cell-free supernatants (CFS), were grouped according to mode-of-action (MOA)
as determined from prior studies. Making a mixture of as many MOAs as possible is a practical
way to obtain a potent natural antimicrobial mixture to address L. monocytogenes contamination
of RTE meat products (i.e., hotdogs). The heat resistance of the bacteriocins allowed the use of
pasteurization to eliminate residual producer cells for use as post-process surface application or their
inclusion into hotdog meat emulsion during cooking. The use of Bac+ LAB comprising 3× MOAs
directly as co-inoculants on hotdogs was not effective at inhibiting L. monocytogenes. However, the
use of multiple MOA Bac+ CFS mixtures in a variety of trials demonstrated the effectiveness of
this approach by showing a >2-log decrease of L. monocytogenes in treatment samples and 6–7 log
difference vs. controls. These data suggest that surface application of multiple mode-of-action
bacteriocin mixtures can provide for an Alternative 2, and possibly Alternative 1, process category as
specified by USDA-FSIS for control of L. monocytogenes on RTE meat products.
Keywords: Listeria monocytogenes; ready-to-eat meats; bacteriocin; mode-of-action; biopreservatives
1. Introduction
Listeria monocytogenes is a formidable foodborne pathogen that causes listeriosis which results
in high hospitalization rates (>90%) and mortalities (20%–30%) in large outbreaks [1]. Vulnerable
populations include immuno-compromised, the sick and elderly, pregnant women, and infants.
Listeria monocytogenes is associated with numerous animals [2] and therefore may be found as a
ubiquitous contaminant on many animal-derived raw food products and ingredients that helps the
organism find its way into meat and poultry processing facilities. The United States Department of
Agriculture’s Food Safety and Inspection Service (USDA-FSIS) found incidences as high as 7.24% on
small cooked sausages (i.e., hotdogs; 1991) and 7.69% on sliced ham and luncheon meats (1996) in
nationwide sampling program for ready-to-eat meats (RTE) in the early 1990’s [3]. Their ability to
remain as a persistent problem in RTE meat processing plants is a combination of their steady influx
on raw ingredients as well as their ability to form biofilms that may resist sanitation efforts and allow
the organism to be a persistent contaminant [4,5].
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The RTE meat industry has been constantly battling the occurrence of L. monocytogenes. While RTE
meats primarily rely on salt, curing agents, and refrigerated storage for microbial stability and safety,
Listeria can capitalize on these conditions by growth at low temperatures and high salt concentrations.
The CDC reported that L. monocytogenes is responsible for 2500 illness cases and 500 deaths annually
(www.cdc.gov/ncidod/disease/foodborn/lister.htm). Hotdogs have maintained a designation as a
high-risk RTE meat for L. monocytogenes because of high contamination rates [6]. Contamination occurs
on the surface of the product during post-process exposure and steps such as peeling and packaging
are potential routes for pathogen entry. The primary hurdle against foodborne pathogens and bacterial
contamination in the food industry includes preventive measures such as good manufacturing practices
(GMPs) and standard operating procedures (SOPs) in addition to a hazard analysis and critical control
point (HACCP) food safety plan required for meat and poultry products [7,8]. Though the food
industry incorporates a variety of precautionary measures, outbreaks due to foodborne illness continue
to occur periodically. Therefore, there is a need for effective antimicrobials that may continue to
provide food safety protection during shelf life and distribution of sensitive products.
The lactic acid bacteria (LAB) are well known for producing antimicrobials including organic
acids, diacetyl, acetoin, hydrogen peroxide, reuterin, reutericyclin, antifungal peptides, and
bacteriocins [9–11]. Although lactic acid is one of the most common acidulants, there has been
considerable interest and research in the field of bacteriocins with respect to use of bacteriocinogenic
(Bac+) LAB cultures or bacteriocin-containing culture fermentates as food preservatives [12].
Bacteriocin-producing cultures have been proposed as protective cultures to combat foodborne
pathogens and spoilage bacteria in food systems [13–17]. The addition of bacteriocins includes
the use of partially purified Bac+ preparations [18] or pre-cultured bacteriocin-containing (Bac+)
cell-free supernatants (CFS) obtained from Bac+ LAB [19] as food ingredients. While the addition
of purified bacteriocins as food preservatives needs regulatory approval and must be treated as
direct food additives, the inclusion of Bac+ CFS from LAB cultures do not have the same regulatory
restrictions [12].
In this study, we examined the effectiveness of Bac+ LAB and Bac+ CFS mixtures to prevent the
growth of L. monocytogenes on RTE meats (hotdogs). Our approach included mixtures of bacteriocins
demonstrating different modes-of-action (MOA), or the strains that produce them, that could provide
enhanced efficacy against L. monocytogenes as opposed to preparations having a single MOA that could
allow the development of spontaneous bacteriocin-resistant L. monocytogenes [20–22].
2. Materials and Methods
2.1. Bacterial Cultures
Strains of LAB were cultured at 30 ◦C in Lactobacilli MRS broth (Difco™, Becton-Dickenson
Laboratories, Sparks, MD, USA) while L. monocytogenes 39-2, an isolate from retail hotdogs [23], was
cultured in tryptic soy broth (TSB, Difco™) at 30 ◦C. Enumeration of LAB from either Bac+ LAB-L.
monocytogenes hotdog challenge studies, or as LAB contaminants in Bac+ CFS-Listeria challenge studies,
was done using MRS agar adjusted with HCl to pH 5.4–5.5 prior to autoclaving (the pH was found
to be ~pH 5.5–5.7 after autoclaving) [24]. Acidified MRS agar inhibited growth of L. monocytogenes
39-2 but allowed the growth of LAB as determined from prior studies. Listeria monocytogenes 39-2 was
selectively enumerated on MOX agar (Modified Oxford agar, Difco™) which was inhibitory to LAB.
The L. monocytogenes 39-2 strain used in this study is resistant to 50 µg/mL of both streptomycin and
rifamycin (Mediatech, Inc., Herndon, VA, USA); plate counts of L. monocytogenes 39-2 were occasionally
confirmed on TS agar containing antibiotics. Bacterial cultures used in this study are listed in Table 1.
Several Bac+ cultures (FS56-1, FS92) were previously identified as Lactococcus lactis and grew well and
made bacteriocins in MRS media; however, during the course of our studies they were identified by
16S rRNA PCR/sequencing to be Enterococcus sp. (Table 1).
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Table 1. Bacterial strains used in this study.
Microorganism Strain Designation Source/Reference
Lactobacillus delbrueckii 4797-2 Muriana culture collection
Listeria monocytogenes 39-2 (R0) [20–23]
Lactobacillus curvatus FS47 [25]
Lactobacillus curvatus Beef 3 [26]
Pediococcus acidilactici Bac 3 [26]
Enterococcus faecium FS56-1 [21,25,26]
Lactococcus lactis FLS-1 [26]
Enterococcus thailandicus RP-1 [21,26]
Enterococcus thailandicus FS92 [21,25]
2.2. Bacteriocin Preparations
Bacteriocins were prepared by 2× repetitive transfer of individual Bac+ LAB overnight at 30 ◦C
followed by centrifugation at 20,000× g (rcf) for 10 min at 4 ◦C (Sorvall RC50 Plus, ThermoFisher
Scientific, Waltham, MA, USA). The supernatants were carefully decanted to sterile bottles and
filter-sterilized through 0.22 µ cellulose acetate syringe filters (VWR, Radnor, PA, USA) or pasteurized
at 80 ◦C for 15 min. Bacteriocin preparations were then stored at 4 ◦C, or frozen at −20 ◦C if not
expected to be used within a few days. Each of the filter-sterilized or pasteurized Bac+ CFS preparations
were also plated on MRSA plates, or into MRS broth, and incubated (30 ◦C) in order to check the
effectiveness of the pasteurization or filter-sterilization process (i.e., no growth).
2.3. Manufacture of Hotdogs for Bacteriocin Applications
Hotdogs were manufactured in-house for use in shelf life trials (Figure 1). Beef and pork trimmings
were used to manufacture hotdogs in the Meat Pilot Plant in the R.M. Kerr Food and Ag Products
Center (FAPC) at Oklahoma State University, Stillwater, OK. Hotdogs were manufactured with the
following formulation (per 35.52 lbs): beef (81% lean; 4.5 lbs), pork (72% lean; 13.25 lbs), pork (42% lean;
7.25 lbs), water/ice (6.25%; 9.45 lbs), Legg’s Bolo seasoning (1.0 lb), cure (6.25% nitrite; 0.06 lb), and
sodium erythorbate (0.01 lbs). Antimicrobials such as lactate and diacetate were not added, as is
commonly done in commercial frankfurters, so as not to confuse the source of antimicrobial activity
during bacteriocin treatments. Emulsions were stuffed into Viscofan 24/USA casings and thermally
processed (cooked) in an electric-fired, batch oven (Alkar, DEC International, Washington, DC, USA)
to an internal temperature of 88 ◦C (190 ◦F). After cooking, hotdogs in casings were chilled with a
cold water rinse and then peeled using a peeling machine (PS760L Peeler, Linker Machines, Rockaway,
NJ, USA). The formulation above was used for surface-treatment with Bac+ CFS or Bac+ LAB applied
prior to packaging. Additional hotdog formulation modifications included replacement of the added
water with pasteurized Bac+ CFS, the use of chilled pasteurized Bac+ CFS spray warm hotdogs still in
casings, and surface application of CFS during packaging (Figure 1). The hotdogs manufactured by
these different protocols were kept separate from each other, vacuum packaged, and stored frozen
until used.
2.4. Hotdog Challenge Studies
2.4.1. Preliminary Treatment of Hotdogs Prior to Challenge Studies
Hotdogs manufactured for use in challenge studies were stored frozen in a blast chiller (−26 ◦C) in
single-layer packages. They were then thawed prior to use and pasteurized by dipping packages into
a temperature-controlled, steam-injected 50-gal hot water bath at 82 ◦C for 5 min in order to eliminate
any indigenous bacterial contaminants that could have been acquired during post-process handling.
Hotdogs were then aseptically removed from the vacuum packages for use in experimental treatments.
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Selected Bac+ LAB cultures covering 3 different MOA were used in these trials: Pe. acidilactici 
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determined by prior enumeration studies. Similarly, L. monocytogenes 39-2 was prepared by dilution 
in sterile 0.1% BPW and 100 µL was inoculated directly into the bagged hotdogs at a level resulting 
in recovery of L. monocytogenes at approximately ~104 cfu/mL from the same minimal rinse recovery 
solutions. The hotdogs in the vacuum bags were then massaged to distribute L. monocytogenes and 
then vacuum-packaged. Bags were stored at 5 °C and sampled at 0 h, 3 days, and weekly at 1, 2, 3, 4, 
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that was kept on ice; this was considered the 10° dilution. Further dilutions were made with 0.1% 
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Figure 1. Manufacture of hotdogs for bacteriocin treatment. (A) Culturing microorganisms;
(B) centrifugation of Bac+ supernatants; (C) pasteurized Bac+ CFS; (D) addition of Bac+ CFS mixture to
hotdog meat matrix (Trial #2); (E) spray bottles with pasteurized Bac+ CFS; (F) pre-cooked hotdogs
in casings; (G) spraying cooked hotdogs in casings with Bac+ CFS mixture (Trial #2); (H) hotdogs
after peeling; (I) addition of hotdogs to vacuum package bags for addition of Bac+ CFS and the
L. monocytogenes inoculum (Trials #3, #4, and #5).
2.4.2. Trial #1: Application of Mixed Mode-of-Action (MOA) Bac+ LAB Co-Inoculated with
L. monocytogenes in Shelf Life Challenge Studies
Selected Bac+ LAB cultures covering 3 different MOA were used in these trials: Pe. acidilactici Bac3
(pediocin Bac3), En. faecium FS56-1 (enterocin FS56), and En. thailandicus FS92 and RP-1 (enterocins
FS92 and RP-1). Freshly grown overnight Bac+ LAB cultures were prepared to approximately similar
levels by dilution in sterile 0.1% BPW and mixed in equal proportions prior to use. Thawed hotdogs
were pasteurized as described above, and then immersed in the Bac+ culture mixture for 30 s using a
sterile plastic basket and allowed to d ain for 30 s before hotdogs were re oved with ste ile tongs to
sterile vacuum packaging bags. A level of mixed Bac+ culture was used for dip ing that would achieve
approximately ~105 cfu/mL in a recovered minimal hotdog rinse as determined by prior enumeration
studies. Similarly, L. monocytogenes 39-2 was prepared by dilution in sterile 0.1% BPW and 100 µL
was inoculated directly into the bagged hotdogs at a level resulting in recovery of L. monocytogenes
at approximately ~104 cfu/mL from the same minimal rinse recovery solutions. The hotdogs in the
vacuum bags were then massaged to distribute L. monocytogenes and then vacuum-packaged. Bags
were stored at 5 ◦C and sampled at 0 h, 3 days, and weekly at 1, 2, 3, 4, 5, 6 and 7 weeks. Triplicate
replications of each treatment (3 bags/treatment) were sampled at the time intervals mentioned above.
During sampling, each package was op ned by snipping open the top c rner, and pipette was used
to deliver 3 mL of iluent (0.1% BPW). The bags were hand-massaged and then a pipette w s used to
withdraw the contents into a sterile disposable plastic tube that was kept on ice; this was considered the
10◦ dilution. Further dilutions were made with 0.1% BPW and plated on acidified MRS agar (for LAB)
or MOX agar (L. monocytogenes). A series of negative control samples containing only L. monocytogenes
39-2 were also included.
2.4.3. Trial #2: Application f Mix d MOA B cteriocin Preparations Added during the Manufacture
of Hotdogs
Hotdogs were manufactured in the FAPC Meat Pilot Plant. Four 25-lb batches of hotdogs were
manufactured which would be used in a variety of trials involving different formulations or treatments.
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Bacteriocin CFS preparations were obtained as described previously (cultured, centrifuged to remove
cells, and pasteurized) and mixed in equal volumes: curvaticin FS47, curvaticin Beef3, lacticin FLS1,
and pediocin Bac3 representing 3 different MOAs.
Control batches of hotdogs did not receive a bacteriocin application; these were also used in
subsequent trials for surface application of a mixed bacteriocin cocktail prior to packaging (see next
section). In the current trial, the mixed bacteriocin CFS preparation was added in place of the water
component (9.45 lbs) in the raw meat emulsion. In an additional formulation and treatment within
this trial, some hotdogs were sprayed after the cook process while still in casings instead of adding
the CFS to the meat matrix. Sprayed Bac+ CFS preparation was allowed to absorb onto the permeable
casing for up to 30 min after which the hotdog casings were peeled and the hotdogs were vacuum
packaged and stored in a blast freezer at −26 ◦C. Prior to use in experiments, hotdogs were thawed
and then pasteurized as described earlier. Hotdogs from these various treatments were then processed
identically: they were placed in vacuum packaging bags (2 hotdogs/bag) with sterile tongs, inoculated
with 100 µL of L. monocytogenes 39-2, hand massaged to evenly distribute the inoculum, and vacuum
packaged. The bags were stored at 5 ◦C and sampled at 0 h, 3 days and weekly at 1, 2, 4, 6, 8, 10, and
12 weeks. Samples were plated on acidified MRS agar (pH 5.5) for enumerating LAB (if present) or
MOX agar for enumerating L. monocytogenes 39-2.
2.4.4. Trial #3: Application of Mixed Mode-of-Action Bac+ CFS on the Surface of RTE Meats (Hotdogs)
Select Bac+ CFS mixtures comprising 3 MOAs were obtained from Lb. curvatus FS47, Lb. curvatus
Beef3, Pe. acidilactici Bac3, En. faecium FS56-1, En. thailandicus FS92, and/or Lc. lactis FLS1. Cultures
were propagated, centrifuged, and CFS was processed as described earlier. Equal volumes of each CFS
was mixed in a sterile tube to obtain a Bac+ CFS mixture comprising 3 MOA; different bacteriocins
were used to obtain the 3 MOA mixture as indicated in the analogous figure legends. As before,
hotdogs were pasteurized as described earlier. Using sterile tongs, pasteurized hotdogs were placed in
vacuum packaging bags (2 hotdogs/bag) to which 300-µL of sterile water (control) or Bac+ CFS was
added, massaged, and then inoculated with 100-µL of L. monocytogenes 39-2, hand-massaged again to
distribute the inoculum, and then vacuum sealed. Samples were then stored at 5 ◦C and sampled at
0 h, 3 days and weekly at 1, 2, 4, 6, 8, 10, and 12 weeks. Samples were plated on acidified MRS agar
(LAB) or MOX agar (L. monocytogenes 39-2).
2.4.5. Trials #4 and #5: Surface Application of Filter vs. Pasteurized Bac+ CFS and Neutralized vs.
Non-Neutralized CFS in L. monocytogenes Challenge Studies on Hotdogs
Several additional modifications of the above were also examined, including a comparison of
filter-sterilized vs. pasteurized Bac+ CFS preparations and pH-neutralized vs. non-neutralized CFS
preparations. A summary of the various trials and treatments received are presented in Table 2.
Table 2. Description of trials and treatments used in this study applying bacteriocin-producing cultures
(Bac+) or their cell free supernatants (CFS) to inhibit L. monocytogenes on RTE meats.
Trial Description of Treatment Data
Trial 1 Use of bacteriocin-producing (Bac+) cultures vs. L. monocytogenes Figure 2
Trial 2
Bac+ CFS added into meat matrix before cooking
Figure 3
Bac+ CFS sprayed onto hotdogs in casings before peeling
Trial 3
Bac+ CFS as surface treatment (includes CFS from 2 Enterococcus strains) Figure 4A
Bac+ CFS as surface treatment (includes CFS from 1 Enterococcus strain) Figure 4B
Trial 4 Bac
+ CFS as surface treatment: All CFS was from traditional lactic acid
bacteria; filter vs. heat-pasteurized Bac+ CFS Figure 5
Trial 5 Bac
+ CFS as surface treatment: Neutralized vs. non-neutralized CFS
and Bac+ vs. Bac− CFS Figure 6
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2.5. Statistical Analysis
Shelf life assays were performed in triplicate and means were plotted versus time. The statistics
functions in SigmaPlot 13 (Systat Software, San Jose, CA, USA) were used to perform one-way
repeated measures analysis of variance (RM-ANOVA) to determine if significant difference exists
between different treatments with level of significance set at 0.05 (p-value).
3. Results and Discussion
3.1. Trial #1: Application of Mixed MOA Bac+ LAB vs. L. monocytogenes on Hotdogs
Trials were performed examining the use of Bac+ LAB cultures as protective co-inoculants
that comprised the 3 MOAs described previously [20,22]. The Bac+ LAB were intentionally added
at approximately 1-log higher level than the co-inoculated L. monocytogenes 39-2. In preliminary
co-inoculation challenge studies with individual Bac+ strains, inhibition of L. monocytogenes 39-2 was
not observed (data not shown). We hoped to demonstrate microbial control of L. monocytogenes by
mixing cultures comprising the 3 MOAs simultaneously vs. L. monocytogenes 39-2. However, we again
did not observe any inhibition of L. monocytogenes in spite of the additional growth during storage
of one or more of the Bac+ strains exceeding that of L. monocytogenes by >3 logs (Figure 2). It is likely
that the storage conditions were unsuitable for the cultures to produce any, or enough, bacteriocin to
be inhibitory to L. monocytogenes 39-2. Although others have shown control of L. monocytogenes on
RTE meats using LAB cultures [27,28], we did not observe this effect and demonstrates the difficulty
in relying on the use of live competitive cultures to provide inhibitory protection to food products
against potential pathogens. Another potential issue with the use of live protective cultures is that the
level required for control, or their potential growth during storage, could be the equivalent of spoilage.
It should be noted that lactic acid produced during culture growth may be buffered by the food matrix
and that bacteriocins are secondary byproducts and their production is not necessarily concomitant
with growth.
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3.2. Trial #2: Listeria Monocytogenes Challenge Studies Using Hotdogs Made with Bacteriocin Extracts Added
during Manufacture or Sprayed Post-Cook onto Encased Products
Additional challenge studies were performed using CFS preparations, either added to the meat
emulsion during manufacture or by manual spray onto the encased hotdogs after cooking, but before
peeling (Figure 1). In prior testing of the heat stability of our bacteriocins, we found that they were
able to tolerate high levels of heating, allowing us to use pasteurization to further insure that extracts
were free of producer cells. Moreover, bacteriocins would provide a greater potential for application if
their thermal tolerance allowed their inclusion in products that may be heated or cooked.
Application of bacteriocins during the manufacture of hotdogs provided excellent control of
L. monocytogenes 39-2 during the 12 weeks of challenge showing a slight decline almost immediately
that continued slowly through 84 days ending at approximately 1-log lower than was initially added
(Figure 3). This level of control is exceptional compared to the >4-log increase observed for the control
treatment and resulted in a difference of 5-logs. As with most applications that depend on ingredients
added to the entire mass of product volume, this treatment required the highest amount of bacteriocin
extract added as an ingredient (i.e., bacteriocin extract was approximately 27% (w/w) of the total
emulsion composition). Another consideration that may occur in such applications is that the active
bacteriocin may be reduced due to interaction with food matrix components during cooking, as it
is known that bacteriocins have hydrophobic motifs that can partition into the fat phase of certain
foods [29,30].
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Figure 3. L. monocytogenes 39-2 challenge study on hotdogs with multiple MOA Bac+ CFS held at 5 ◦C
for up to 84 days in vacuum packages (Trial #2). L. monocytogenes 39-2 was inoculated onto untreated
hotdogs (Lm, alone), inoculated onto hotdogs in which the bacteriocin mixture was mixed into the meat
emulsion during manufacture (in emulsion Bac+), or inoculated onto hotdogs in which the bacteriocin
mixture was previously sprayed while hotdogs were still in casings before peeling (in spray Bac+). The
Bac+ CFS was comprised of curvaticin FS47, curvaticin Beef3, pediocin Bac3, and lacticin FLS1. Platings
for LAB from all treatments were made on acidified MRS (hollow symbols). All sample treatments
were performed in triplicate replication; data points represent the means and error bars represent
the standard deviation from the means. Treatments with different letters are significantly different
(repeated measures, p < 0.05).
In contrast, the cooked and encased product that was sprayed with bacteriocin before peeli g
showed moderate inhibition elativ to the control treatment (Figure 3). Although ome bacteriocin
probably penetrated the permeable casing, most of it likely washed off. Although a smaller amount
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was used to spray the encased hotdogs than when included in the meat matrix, one could argue it
may be more effective to spray hotdogs after peeling than before peeling, and is reflected in our next
approach. In the Bac+ CFS challenge with L. monocytogenes, we also plated the liquid recovered from
packages for potential indigenous lactic acid bacteria. We were careful to pasteurize our cooked, frozen,
and thawed hotdogs prior to use in challenge studies and did not want production of lactic acid from
potential indigenous bacteria to influence interpretation of inhibition from added bacteriocin. The
data indicates that indigenous LAB were below our limit of detection and did not contribute to the
inhibition observed. In real commercial applications, of course any further contributory inhibition by
lactic acid contributed by indigenous LAB would be welcome to help inhibit potential pathogens such
as Listeria. The bacteriocin mixture might have also been inhibitory to potential contaminating LAB as
well (i.e., sensitive).
3.3. Trials #3, #4, and #5: Listeria monocytogenes Challenge Studies with Multiple-MOA Bacteriocin Extracts
Added after Peeling (During Packaging)
Several trials were conducted by adding CFS preparations directly to packages prior to vacuum
packaging. These applications utilize the least amount of bacteriocin because they are applied on the
product surface after cooking and vacuum packaging can provide a tight space for them to perform
as a thin film between food product and packaging film where most surface microorganisms may
be found. Most post-process contamination of RTE meats usually occurs on the product surface,
as L. monocytogenes is mostly a surface problem resulting from contact with contaminated food
contact surfaces.
During the progression of our studies, we used a variety of strains that were grouped according
to MOA as described earlier. We confirmed the identity of our organisms using 16S rRNA PCR
amplification followed by sequencing for both old stock cultures and newly identified strains as
reported elsewhere [26]. The use of 16S rRNA analysis had shown that some strains previously
identified as Lactococcus by API metabolic assays were actually Enterococcus [25,26]. Enterococcus sp.
are commonly isolated from foods [31], some are even used as starter cultures [32] and still others
as probiotics [33]. However, their use in foods has been challenged because of their involvement
as opportunistic human pathogens [34]. We don’t feel the use of Enterococcus strains are a problem
with our work because of the use of cell-free extracts rather than live strains. However, we were still
interested in seeing if we could develop a repertoire of strains comprised solely of bacteriocin extracts
from what is generally considered traditional ‘food-grade’ lactic acid bacteria should cell-free extracts
from enterococcal strains become a debilitating issue.
Figure 4 represents several hotdog challenge studies whereby we used 2 enterococcal bacteriocins
(Figure 4A) and then traded out one of them out for a lactococcal bacteriocin and used only
1 enterococcal bacteriocin (Figure 4B). There was moderate inhibition and control of L. monocytogenes
when CFS was added to the meat matrix before cooking (Figure 3). However, when Bac+ CFS was
surface-applied, the data shows a significant drop in L. monocytogenes within the first few days of
storage (~2 logs) and continues until about 7–10 days showing a stable level of L. monocytogenes at or
near the limit of detection (Figure 4A,B).
The USDA-FSIS regulations for ‘control of L. monocytogenes in RTE meats’ specifies conditions
for several risk categories of RTE meats whereby an Alternative 1 process (least risk) is described as
possessing a post-process lethality step for L. monocytogenes (i.e., ≥1-log reduction) and control of
L. monocytogenes (i.e., ≤2-log increase) during shelf life [35]. This is often obtained by two separate
mechanisms but can also be achieved by a single treatment. The data presented herein may satisfy
those requirements for both post-process lethality and control of L. monocytogenes during shelf life
using a single surface treatment with these bacteriocin preparations.
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Figure 4. Hotdog challenge study with surface-applied bacteriocin extracts comprising 3 mixed MOAs.
L. monocytogenes 39-2 was either inoculated onto hotdogs alone (as control) or with added bacteriocin
extracts (Trial #3). (A) bacteriocin extracts included curvaticin FS47, pediocin Bac3, enterocin FS56-1,
and enterocin FS92. (B) bacteriocin extracts included curvaticin FS47, pediocin Bac3, enterocin FS56-1,
and lacticin FLS1. Plate counts for LAB from these treatments were made on acidified MRS (hollow
symbols). All sample treatments were performed in triplicate replication; data points represent the
means and error bars represent the standard deviation from the means. Treatments with different
letters are significantly different (repeated measures, p < 0.05).
We further ex mined the use of Bac+ CFS preparations as hotdog surface treatments using
only traditio al lactic acid bacteria from our collection that complied with the 3 mod of
actions defined earlier. Using this approach, we also compared the efficacy of filter-sterilized vs.
heat-pasteurized bacteriocins (Figure 5). The data appears no different when using filter-sterilized
vs. heat-pasteurized bacteriocin extracts demonstrating that heat pasteurization (after centrifugation)
imparts no detrimental effect to the bacteriocins and is an easy method of eradicating residual
bacteriocin-producer cells (Figure 5). The initial decrease of L. monocytogenes was not as dramatic
as that observed with the enterococcal bacteriocins (Figure 4). We ascribe this to the moderate
production of bacteriocin FLS1 by Lactococcus lactis FLS1 compared to that produced by others in
the CFS. The enterococcal strains have also been shown to possess genes for multiple enterocins [21].
L. monocytogenes increased approximately 5-log in control samples, showing >6.5-log difference between
control and treatments. Again, LAB were not detected within the trials and demonstrates that inhibitory
action was again solely provided by the added bacteriocins.
Since LAB bacteriocin culture extracts may also contain lactic acid, we further examined the use of
neutralized vs. non-neutralized CFS from both Bac+ (bacteriocin treatment) and bacteriocin-negative
(Bac−, c trol) LAB in order to more confidently assert the inhibition to bacteriocin-related
antimicrobial activity (Figure 6). The use of Bac− LAB culture extract (Lb. delbrueckii 4797) was
an additional control treatm nt to evaluate whether lactic ac d produced by cultures (without the
influence of bacteriocin) was contributory to the inhibition observed in these assays as we have
observed a contributory effect of lactic acid in culture extracts in microplate in vitro assays [22].
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(curvaticin FS47 and Beef3, pediocin Bac3, and lacticin FLS1; Trial #4). L. monocytogenes 39-2 was
either inoculated on hotdogs alone, or with added heat-treated or filter-sterilized CFS preparations,
vacuum-packaged, and held for up to 12 weeks at 5 ◦C. Platings for LAB from these 3 treatments were
also made on acidified MRS (hollow symbols). All sample treatments were performed in triplicate; data
points r present the means and error bars represent th standard deviation from the means. Treatments
with different l ters are significa ifferent (repeated measures, p < 0.05); those sharing the same
letter are not significantly different, p > 0.05).
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Figure 6. Hotdog challenge study vs. L. monocyto -2 ith surface-applied bacteriocin extracts
(+Bac) comprising mixed MOAs (curvaticin FS eef3, pediocin Bac3, and lacticin FLS1) and
neutralized (+Neut) vs. non-neutaliz d (-Neut) culture extracts (Trial #5). Lb. delbueckii 4797 was
used for bacteriocin-negative (-Bac) CFS extracts that were also used both neutralize (+Neut) and
non-neutralized (-Neut). All sample treatments were performed in triplicate replication; data points
represent the mean and error bars represent the standard deviation from the mean. Treatments with
different letters are significantly different (repeated measures, p < 0.05); those sharing the same letter
are not significantly different, p > 0.05).
The data shows that addition of neutralized (-Bac, +Neut) or non-neutralized (-Bac, -Neut) CFS
extracts from a Bac− LAB culture did not show any inhibition of L. monocytogenes in comparison to the
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control treatment in which sterile water was added instead of Bac− culture extracts (Figure 6). Although
the treatments whereby CFS from a Bac− culture were added showed no significant difference to
L. monocytogenes 39-2 to which water was added instead of CFS, they did have slightly higher growth
levels, perhaps attributed from additional nutrients from the CFS. The main point was that lactic acid
in the Bac− extracts did not inhibit L. monocytogenes (Figure 6). In another study using microplate
in vitro assays, we observed definite lactic acid effects when comparing the effects of neutralized
vs. non-neutralized extracts [22]. We suggest that the difference lies in the microplate assay format
whereby culture extracts comprised approximately 30% of the assay volume in prior in vitro assays [22]
whereby in these assays the added culture extracts comprised <0.1% of the package weight which
contained substantial organic material (i.e., hotdogs) that can readily buffer the effects of organic
acids from even non-neutralized extracts. Addition of the multi-MOA bacteriocin mixture resulted
in approximately a 2-log reduction of L. monocytogenes within the first 1–3 days of addition that did
not show any increase (beyond the initial added level) during the 12-week challenge study, showing
~7-log difference from controls. These data again suggest that these treatments satisfy the requirements
for USDA-FSIS Alternative 1 product classification for RTE meat and poultry products [35].
4. Conclusions
The data presented herein shows the efficacious application of a mixture of bacteriocins against
L. monocytogenes. The bacteriocin-producing strains were isolated from various sources including foods
found in supermarkets [25,26], however it was the unique method of procuring and using spontaneous
resistant mutants as ‘microbial screens’ to categorize them into different modes of action (MOA) [20–22]
and then using a mixture comprising those different MOAs in order to provide an effective cocktail of
natural antimicrobial bacteriocins that active synergistically to inhibit L. monocytogenes in RTE meats as
observed in this study. Although others are also using surface application of bacteriocins [36], we feel
that the multiple MOA approach works well to minimize the possible development of spontaneous
bacteriocin-resistant mutants that readily occurs with bacteriocins of similar MOA [20,21]. Since our
bacteriocins are heat resistant, they can be added in, or on, foods that may be heated or cooked.
The use of culture extracts provides an opportunity for the biological activity to be standardized
whereas the use of live cultures to provide antimicrobial protection in non-actively growing situations
is tenuous. We feel that such bacteriocin extracts produced by food-grade LAB may be used freely as
food ingredients to act as food preservatives (i.e., biopreservatives) in RTE meats and other products
where they show proven efficacy against targeted pathogens and susceptible spoilage organisms.
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